Harnessing Polymer Biophysics for
Superior Biotechnology Therapies
About Valitor
Valitor is developing a new generation of biotechnology therapies that have been engineered to outperform conventional therapeutics by orders of magnitude
We combine biotechnology with biophysics to maximize the pharmacological performance of our therapeutic products and enable unprecedented efficacy and safety profiles
Our lead product has been designed to disrupt several major markets in ophthalmology. Our core technology has also been applied to a broad set of indications, including immuno-oncology and treatments for inflammation
Our technology
Our core technology platform originated at UC Berkeley and enables us to generate multivalent protein (MVP) conjugates by tethering multiple copies of bioactive molecules (e.g., camelid antibodies, cytokines, etc.) to single-chain, soluble biopolymers. Using Valitor’s propriety compositions and chemistry methods, our MVPs exhibit the following advantages over other therapeutic products that are either on the market or in development:
Extended Target Tissue Retention
Superior Pharmacokinetics
Protection from Deactivation
Engineered for
High Potency
Designed from Endogenous Materials
Superior Pharmaco-stability
Superior Pharmacodynamics
Superior Safety Profile
Contact Us
Valitor, Inc.
East Bay Innovation Center
820 Heinz Avenue
Berkeley, CA 94710
Phone: (510) 545-6062
Fax: (510) 647-8429
Email:
For any general inquiries, please fill in the following contact form: